JP2011517443A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011517443A5 JP2011517443A5 JP2011500192A JP2011500192A JP2011517443A5 JP 2011517443 A5 JP2011517443 A5 JP 2011517443A5 JP 2011500192 A JP2011500192 A JP 2011500192A JP 2011500192 A JP2011500192 A JP 2011500192A JP 2011517443 A5 JP2011517443 A5 JP 2011517443A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- substituents
- hydrogen
- defined above
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3746308P | 2008-03-18 | 2008-03-18 | |
| US61/037,463 | 2008-03-18 | ||
| EP08152873 | 2008-03-18 | ||
| EP08152873.9 | 2008-03-18 | ||
| PCT/EP2009/053133 WO2009115515A1 (en) | 2008-03-18 | 2009-03-17 | Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011517443A JP2011517443A (ja) | 2011-06-09 |
| JP2011517443A5 true JP2011517443A5 (enExample) | 2012-04-26 |
| JP5504252B2 JP5504252B2 (ja) | 2014-05-28 |
Family
ID=39639064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011500192A Expired - Fee Related JP5504252B2 (ja) | 2008-03-18 | 2009-03-17 | ５−ｈｔ６アンタゴニストとしてのアリールスルホニルピラゾリンカルボキシアミジン誘導体 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US8563723B2 (enExample) |
| EP (2) | EP2265589B1 (enExample) |
| JP (1) | JP5504252B2 (enExample) |
| KR (1) | KR101623357B1 (enExample) |
| CN (2) | CN104003937A (enExample) |
| AR (1) | AR070898A1 (enExample) |
| AU (1) | AU2009226956C1 (enExample) |
| BR (1) | BRPI0908738A8 (enExample) |
| CA (1) | CA2717922A1 (enExample) |
| CO (1) | CO6290679A2 (enExample) |
| CR (1) | CR11742A (enExample) |
| DK (2) | DK2265589T3 (enExample) |
| DO (2) | DOP2010000276A (enExample) |
| EA (1) | EA023176B1 (enExample) |
| EC (1) | ECSP10010476A (enExample) |
| ES (2) | ES2565184T3 (enExample) |
| HK (1) | HK1201823A1 (enExample) |
| IL (1) | IL207846A0 (enExample) |
| MX (1) | MX2010010299A (enExample) |
| MY (1) | MY155318A (enExample) |
| NZ (1) | NZ587743A (enExample) |
| PH (1) | PH12013502376A1 (enExample) |
| PL (2) | PL2265589T3 (enExample) |
| PT (1) | PT2610247T (enExample) |
| SG (1) | SG183688A1 (enExample) |
| TW (1) | TWI557110B (enExample) |
| UA (1) | UA105629C2 (enExample) |
| WO (1) | WO2009115515A1 (enExample) |
| ZA (1) | ZA201006272B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR079935A1 (es) * | 2010-01-29 | 2012-02-29 | Abbott Healthcare Products Bv | Sintesis de derivados de pirazolin carboxamidina sustituida |
| BR112014003382B1 (pt) * | 2011-08-15 | 2022-03-15 | University Of Utah Research Foundation | Análogos de (e)-n-(1-feniletilideno) benzo-hidrazida substituída como inibidores de histona desmetilase e composições farmacêuticas compreendendo-os |
| SG11201503556PA (en) * | 2012-11-16 | 2015-06-29 | Bristol Myers Squibb Co | Dihydropyrazole gpr40 modulators |
| EP2925726B1 (en) * | 2012-11-16 | 2016-10-26 | Bristol-Myers Squibb Company | Dihydropyrazole gpr40 modulators |
| EA026913B1 (ru) * | 2012-11-16 | 2017-05-31 | Бристол-Майерс Сквибб Компани | Дигидропиразольные модуляторы gpr40 |
| AU2015255765A1 (en) * | 2014-05-09 | 2016-11-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Pyrazole derivatives and their use as cannabinoid receptor mediators |
| EP3180312B1 (en) | 2014-08-12 | 2019-10-16 | Loyola University Of Chicago | Indoline sulfonamide inhibitors of dape and ndm-1 and use of the same |
| EP3109237A1 (en) * | 2015-06-22 | 2016-12-28 | AnaMar AB | Novel 5-ht2 antagonists |
| CN107460160A (zh) * | 2017-08-23 | 2017-12-12 | 世贸天阶制药（江苏）有限责任公司 | 一种cho细胞无血清培养基 |
| US10879709B2 (en) | 2018-05-31 | 2020-12-29 | National Taipei University Of Technology | Power management system and operating method thereof |
| TW202128664A (zh) | 2019-10-09 | 2021-08-01 | 德商拜耳廠股份有限公司 | 作為除害劑之新穎雜芳基三唑化合物 |
| CA3185968A1 (en) | 2020-07-13 | 2022-01-20 | Tony Lahoutte | Antibody fragment against folr1 |
| WO2023203135A1 (en) | 2022-04-22 | 2023-10-26 | Precirix N.V. | Improved radiolabelled antibody |
| CN119584994A (zh) | 2022-05-02 | 2025-03-07 | 普雷西里克斯公司 | 预靶向 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0402113A3 (en) * | 2001-09-21 | 2012-05-29 | Solvay Pharm Bv | 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof |
| GB0422263D0 (en) * | 2004-10-07 | 2004-11-10 | Glaxo Group Ltd | Novel compounds |
| SA07280510B1 (ar) * | 2006-09-22 | 2012-02-07 | سولفاي فارماسوتيكالز بي . في | سلفونيل بيرازول ومشتقات سلفونيل كربوكساميدين كمضادات ht6-5 |
-
2009
- 2009-03-13 AR ARP090100917A patent/AR070898A1/es unknown
- 2009-03-16 TW TW098108412A patent/TWI557110B/zh not_active IP Right Cessation
- 2009-03-17 CN CN201410233817.3A patent/CN104003937A/zh active Pending
- 2009-03-17 SG SG2012057592A patent/SG183688A1/en unknown
- 2009-03-17 PL PL09721279T patent/PL2265589T3/pl unknown
- 2009-03-17 BR BRPI0908738A patent/BRPI0908738A8/pt not_active IP Right Cessation
- 2009-03-17 MX MX2010010299A patent/MX2010010299A/es active IP Right Grant
- 2009-03-17 JP JP2011500192A patent/JP5504252B2/ja not_active Expired - Fee Related
- 2009-03-17 NZ NZ587743A patent/NZ587743A/en not_active IP Right Cessation
- 2009-03-17 WO PCT/EP2009/053133 patent/WO2009115515A1/en not_active Ceased
- 2009-03-17 KR KR1020107022926A patent/KR101623357B1/ko not_active Expired - Fee Related
- 2009-03-17 EP EP09721279.9A patent/EP2265589B1/en active Active
- 2009-03-17 UA UAA201012295A patent/UA105629C2/uk unknown
- 2009-03-17 EP EP13161112.1A patent/EP2610247B1/en not_active Not-in-force
- 2009-03-17 ES ES09721279.9T patent/ES2565184T3/es active Active
- 2009-03-17 US US12/933,182 patent/US8563723B2/en not_active Expired - Fee Related
- 2009-03-17 ES ES13161112.1T patent/ES2577867T3/es active Active
- 2009-03-17 AU AU2009226956A patent/AU2009226956C1/en not_active Ceased
- 2009-03-17 DK DK09721279.9T patent/DK2265589T3/en active
- 2009-03-17 PT PT131611121T patent/PT2610247T/pt unknown
- 2009-03-17 PL PL13161112T patent/PL2610247T3/pl unknown
- 2009-03-17 CA CA2717922A patent/CA2717922A1/en not_active Abandoned
- 2009-03-17 DK DK13161112.1T patent/DK2610247T3/en active
- 2009-03-17 MY MYPI2010004094A patent/MY155318A/en unknown
- 2009-03-17 CN CN200980108113.0A patent/CN102036967B/zh not_active Expired - Fee Related
- 2009-03-17 EA EA201071083A patent/EA023176B1/ru not_active IP Right Cessation
-
2010
- 2010-08-29 IL IL207846A patent/IL207846A0/en unknown
- 2010-09-01 ZA ZA2010/06272A patent/ZA201006272B/en unknown
- 2010-09-13 DO DO2010000276A patent/DOP2010000276A/es unknown
- 2010-09-13 EC EC2010010476A patent/ECSP10010476A/es unknown
- 2010-09-14 CO CO10113567A patent/CO6290679A2/es active IP Right Grant
- 2010-09-14 DO DO2010000277A patent/DOP2010000277A/es unknown
- 2010-10-15 CR CR11742A patent/CR11742A/es unknown
-
2011
- 2011-07-05 HK HK15101929.7A patent/HK1201823A1/xx unknown
-
2013
- 2013-09-11 US US14/024,030 patent/US8901108B2/en not_active Expired - Fee Related
- 2013-11-18 PH PH12013502376A patent/PH12013502376A1/en unknown
-
2014
- 2014-10-29 US US14/527,651 patent/US9126942B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011517443A5 (enExample) | ||
| RU2470011C2 (ru) | Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов | |
| RU2286988C2 (ru) | Производные 4,5-дигидро-1h-пиразола, обладающие сильной cb1-антагонистической активностью | |
| JP2009538910A5 (enExample) | ||
| JP2010520264A5 (enExample) | ||
| AU2002237654B2 (en) | Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders | |
| JP2005526723A5 (enExample) | ||
| JP2004527467A5 (enExample) | ||
| JP2004518763A5 (enExample) | ||
| JP2002523508A5 (enExample) | ||
| JP2019069966A (ja) | Ｃｎｓおよび他の障害を治療するための、ｐｄｅ４アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 | |
| JP2010520265A5 (enExample) | ||
| JP2010529045A5 (enExample) | ||
| KR20150013189A (ko) | 벤조티오펜 화합물 또는 이의 염의 2수화물, 및 이의 제조 방법 | |
| JP2011530521A5 (enExample) | ||
| US10023534B2 (en) | Carbazole and tetrahydrocarbazole compounds useful as inhibitors of BTK | |
| JP2015508092A5 (enExample) | ||
| JP2007500168A5 (enExample) | ||
| CN106255690B (zh) | 光学活性pde10抑制剂 | |
| JP2015502371A5 (enExample) | ||
| JP2013526610A5 (enExample) | ||
| JP2008542365A5 (enExample) | ||
| EP2616460B1 (en) | Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine. | |
| JP2008508251A5 (enExample) | ||
| JP2019518756A5 (enExample) |